Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: Multicentre, single-arm, phase 2 study

Michael Wang, Leslie L. Popplewell, Robert H. Collins, Jane N. Winter, Andre Goy, Mark S. Kaminski, Nancy L. Bartlett, Patrick B. Johnston, John Lister, Suzanne R. Fanning, Joseph M. Tuscano, J. Thaddeus Beck, Hakan Kaya, Anna Robeva, Jenna Fan, Judith Klimovsky, Wing Cheung, Azzeddine Cherfi, Owen A. O'Connor